Eastland Julie's most recent trade in Lantheus Holdings Inc was a trade of 4,543 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lantheus Holdings Inc | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 4,543 | 4,543 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 2,537 | 3,882 (0%) | 0% | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Julie Eastland | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 59,388 | 87,888 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Julie Eastland | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 59,388 | 59,388 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Julie Eastland | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 31 Jan 2025 | 28,500 | 28,500 | - | 1.7 | 49,345 | Common Stock |
| Zentalis Pharmaceuticals Inc | Eastland Julie | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 3,028,800 | 3,028,800 | - | - | Stock Option (Right to Buy) | |
| Lantheus Holdings Inc | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 2,506 | 2,506 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 1,345 | 1,345 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 5,357 | 16,071 (0%) | 0% | 0 | Common Stock | |
| Harpoon Therapeutics Inc | Eastland Julie | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2024 | 178,500 | 232,003 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 5,357 | 10,714 (0%) | 0% | 0 | Common Stock | |
| CalciMedica Inc | Julie Eastland | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 0 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Julie Eastland | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 1,429 | - | - | Common Stock | |
| Harpoon Therapeutics Inc | Julie Eastland | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 407,600 | 407,600 | - | - | Employee Stock Option (right to buy) | |
| CalciMedica Inc | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| CalciMedica Inc | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 22,500 | 22,500 | - | - | Option (Right to Buy) | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 5,357 | 5,357 | - | - | Restricted Stock Unit | |
| Harpoon Therapeutics Inc | Julie Eastland | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 25,000 | 25,000 | - | - | Option (Right to Buy) | |
| CalciMedica Inc | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Julie Eastland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |